Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604043 · ClinicalTrials.gov registry record · NA
Continuous Supraglottic pH Monitoring in Prolonged Intubated Intensive Care Patients and High Risk Aspiration Intraoperative Patients
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02604043 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 3 participants.
The verdict
NCT02604043, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a pilot prospective cohort study of the incidence of supraglottic pH readings.
Interventions
- OTHER pH monitoring
- OTHER accelerometer monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604043
The ClinicalTrials.gov registry entry for NCT02604043 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pH monitoring is the first listed.
NCT02604043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02604043 about?
NCT02604043 is a clinical study titled "Continuous Supraglottic pH Monitoring in Prolonged Intubated Intensive Care Patients and High Risk Aspiration Intraoperative Patients". This is a pilot prospective cohort study of the incidence of supraglottic pH readings.
What is the current status of trial NCT02604043?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-08. Estimated completion is 2018-07-01.
What interventions are being tested in trial NCT02604043?
The interventions under investigation include: pH monitoring (OTHER), accelerometer monitoring (OTHER).
Who is sponsoring clinical trial NCT02604043?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.